PhRMA Comments to the 2017 National Trade Estimate Report
The attached submission, presented to the Trade Policy Staff
Committee of the Executive Office of the President on behalf of PhRMA
and its member companies, identifies significant barriers to the export
of goods, services and overseas direct investment for for inclusion in
the 2017 National Trade Estimate Report (NTE).